1. TRIAL NAME
Presenter NAME
Article Reference

2. Picture of trial
DEFINE the TRIAL ACRONYM

3. BACKGROUND
Key points
Points about why trial was made
ADD PICTURE HERE

4. Clinical question
WHAT IS THE CLINICAL QUESTION OF TRIAL?
PICTURE

5. DESIGN Analysis: Where was it performed? N= ? Setting:
Group 1
Group 2
Setting:
Median follow-up: ?
Primary outcome: __
Secondary outcomes: __

6. Population Inclusion Criteria Exclusion Criteria Key Points
Contraindication to anticoagulation therapy
Ineligible to undergo trials of ≥2 medications in either treatment strategy

7. Interventions Group 1 Group 2 (Placebo Control)
DESCRIBE
Group 2 (Placebo Control)
Describe
Any other key points re: interventions?

8. RESULTS

9. RESULTS

10. criticisms
Criticism 1
Criticism 2
Criticism 3

11. Bottom line
ONE LINER ON TAKE AWAY POINTS

12. Discussion questions Discussion question 1 Discussion question 2

13. Discussion ANSWERS Discussion question 1 Discussion question 2

14. BOARD-LIKE Question QUESTION What/When/Where/Who/Why_? _
70 yo male __ PE: Labs: Imaging: (Adapted from MKSAP)

15. BOARD-LIKE Question QUESTION Educational Objective: _
Key Point:
Point 1
Point 2
QUESTION
What/When/Where/Who/Why_? _

16. CLINICAL PEARL
Changes in guideline?
How to apply to daily practice?

17. REFERENCES